Has Jessica Holliday, MD received payments from drug or device companies?

Yes. Drug and device makers reported $331 in general payments to Jessica Holliday, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Holliday, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Holliday, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Holliday, MD

Psychiatry · San Francisco, CANPI 1114389574

Payments from drug & device makers

$331in general payments, 2019–2025

Across 15 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Axsome Therapeutics, Inc.$66
Otsuka America Pharmaceutical, Inc.$65
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48
Supernus Pharmaceuticals, Inc.$34
Neurocrine Biosciences, Inc.$32
Johnson & Johnson$30
plus $56 from 3 others

What the payments were for

Food & beverage$331100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Axsome Therapeutics, Inc.	2	$66
Otsuka America Pharmaceutical, Inc.	3	$65
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$48
Supernus Pharmaceuticals, Inc.	2	$34
Neurocrine Biosciences, Inc.	1	$32
Johnson & Johnson	2	$30
Biogen	1	$25
AbbVie	1	$16
Ironshore Pharmaceuticals Inc.	1	$15

How this compares

$331 in reported general payments places this provider in the 60th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$99,465

Medicare patients

125

Services billed

1,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mirtazapine	114	$4,153
Venlafaxine Hcl ErVenlafaxine Hcl	71	$3,936
Bupropion XlBupropion Hcl	56	$3,695
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	15	$1,891
Duloxetine Hcl	75	$1,821
Quetiapine Fumarate	75	$1,792
Escitalopram Oxalate	80	$1,270
Aripiprazole	32	$1,070
Clonazepam	73	$981
Atomoxetine Hcl	12	$817
Fluoxetine Hcl	59	$712
Venlafaxine Hcl	45	$661
Trazodone Hcl	62	$648
Nortriptyline Hcl	17	$587
Doxepin Hcl	12	$502

Paid to pharmacies, not to this prescriber.

Other psychiatry in San Francisco

John KooSan Francisco$3M
Corinna GamezSan Francisco$2M
Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →